The Middle East life sciences industry has seen remarkable growth, fueled by improved diagnostic capabilities, a rising burden of chronic and acute diseases, and advancements in translational research. Countries like Saudi Arabia, Egypt, Turkey, and the United Arab Emirates (U.A.E.) are becoming regional leaders, with the U.A.E. establishing itself as the center of life sciences in the MENA region. To improve healthcare results, these countries are progressively implementing cutting-edge technologies and precision medicine. A variety of technologies, such as PCR, NGS, and cell culture, are driving the industry. Despite obstacles such a shortage of experienced workers and unequal uptake of cutting-edge instruments, increased post-COVID-19 knowledge of molecular diagnostics is driving industry growth.

What is the expected CAGR or market size forecast for the coming years?
The Middle East Life Sciences Market was valued at $306.0 million in 2022 and is projected to reach $813.1 million by 2032, growing at a CAGR of 10.27% during the forecast period (2022–2032).

Who are the major players or companies operating in the Middle East life sciences market?

• Thermo Fisher Scientific

• Illumina

• Bio‑Rad Laboratories 

• QIAGEN

• GE Healthcare / Cytiva 

• Hikma Pharmaceuticals

Which countries in the Middle East are leading in life sciences development?

• United Arab Emirates (UAE)

• Saudi Arabia

• Qatar

• Israel

• Jordan

• Egypt

• Bahrain

How are Saudi Arabia and UAE advancing their life science sector?

With the goal of becoming a global biotech powerhouse by 2040 and a leader in the MENA region by 2030, Saudi Arabia unveiled its National Biotechnology Strategy in January 2024. The UAE is concentrating on growing the biotechnology sector as a significant subsector under Abu Dhabi Vision 2030.

Get your hands on this Sample Report to stay up-to-date on the latest developments in this Market!

Learn more about Healthcare Vertical. Click Here! 

Conclusion

The Middle East life sciences market is poised for significant growth, driven by advancements in genomics, proteomics, and cell biology. With an emphasis on digital transformation and precision medicine, the area is poised to overcome obstacles including logistical delays and a lack of competent workers. The Middle East's standing as a global center for life sciences innovation will be further cemented by strategic investments in infrastructure development and public-private collaborations.